Carolyn S Grove

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 5

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Chemotherapy Induced

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

David T Yeung, Naranie Shanmuganathan, John Reynolds, Susan Branford, Mannu Walia, Agnes Sm Yong, Jake Shortt, Lynette Chee, Nicholas Viiala, Ilona Cunningham, David Morrall Ross, Alwyn Bernard D'Souza, Matthew Wright, Rosemary Anne Harrup, Cecily Jane Forsyth, Robin Filshie, Steven W Lane, Peter J Browett, Carolyn S Grove, Andrew A Grigg, Timothy P Hughes
Asciminib Monotherapy as Frontline Treatment of Chronic-Phase Chronic Myeloid Leukemia: Results from the ASCEND Study. Blood (2024)
Ghayas C Issa, Ibrahim Aldoss, Michael J Thirman, John F Dipersio, Martha Arellano, James S Blachly, Gabriel N Mannis, Alexander E Perl, David S Dickens, Christine M McMahon, Jennifer Dunlap, Christian Michel Zwaan, Carolyn S Grove, Richard M Stone, Paul J Shami, Ioannis Mantzaris, Matthew Greenwood, Neerav N Shukla, Branko Cuglievan, Tibor Kovacsovics, Yu Gu, Rebecca G Bagley, Kate Madigan, Yakov Chudnovsky, Huy Van Nguyen, Nicole McNeer, Eytan M Stein
Menin Inhibition With Revumenib for KMT2A -Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Stéphane de Botton, Pierre Fenaux, Karen W L Yee, Christian Recher, Andrew H Wei, Pau Montesinos, David C Taussig, Arnaud Pigneux, Thorsten Braun, Antonio Curti, Carolyn S Grove, Brian A Jonas, Asim Khwaja, Ollivier Legrand, Pierre Peterlin, Montserrat Arnan, William Blum, Daniela Cilloni, Devendra K Hiwase, Joseph G Jurcic, Jürgen Krauter, Xavier G Thomas, Justin M Watts, Jay Yang, Olga Polyanskaya, Julie Brevard, Jennifer Sweeney, Emma Barrett, Jorge E Cortes
Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AML. Blood advances (2023)
Ing Soo Tiong, Richard Dilon, Adam Ivey, James A Kuzich, Nisha Thiagarajah, Kirsty M Sharplin, Chung Hoow Kok, Aditya Tedjaseputra, James P Rowland, Carolyn S Grove, Emad Abro, Jake Shortt, Devendra K Hiwase, Ashish Bajel, Nicola E Potter, Matthew L Smith, Claire J Hemmaway, Abin Thomas, Amanda F Gilkes, Nigel H Russell, Andrew H Wei
Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia. Blood advances 5 (23) (2022)
Samuel J Taylor, Johanna M Duyvestyn, Samantha A Dagger, Emma J Dishington, Catherine A Rinaldi, Oliver M Dovey, George S Vassiliou, Carolyn S Grove, Wallace Y Langdon
Preventing chemotherapy-induced myelosuppression by repurposing the FLT3 inhibitor quizartinib. Science translational medicine 9 (402) (2018)